Glycemic index, glycemic load: New evidence for a link with acne

Journal of the American College of Nutrition

Volumn 28, Issue , 2009, Pages 450S-454S

  Berra, Bruno ^a   Rizzo, Angela Maria ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Acne; Glycemic index; Glycemic load; IGF 1

Indexed keywords

ANDROGEN; MONOUNSATURATED FATTY ACID; PALMITIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; SATURATED FATTY ACID; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACNE; ANDROGENESIS; CACAO; CARBOHYDRATE INTAKE; DIETARY INTAKE; GLYCEMIC INDEX; GLYCEMIC LOAD; HYPERINSULINEMIA; INSULIN RESISTANCE; MILK; OVARY POLYCYSTIC DISEASE; REVIEW; SEBUM SECRETION; SKIN INFLAMMATION;

ACNE VULGARIS; ANDROGENS; BLOOD GLUCOSE; DIET; GLYCEMIC INDEX; HUMANS; HYPERINSULINISM; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; SEBUM; SKIN;

EID: 77951528067     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2009.10718111     Document Type: Article

References (59)

1. Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton B, Brand-Miller B: Acne vulgaris—a disease of Western civilization. Arch Dermatol 138:1584–1590, 2002.
2. Schaefer O: When the Eskimo comes to town. Nutr Today 6:8–16, 1971.
3. Steiner P: Necropsies on Okinawans: anatomic and pathologic observations. Arch Pathol 42:359–380, 1946.
4. Smith RN, Mann NJ, Braue A, Mächeläinen H, Varigos JA: A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am J Clin Nutr 86:107–115, 2007.
5. Smith RN, Mann N, Makelainen H, Roper J, Braue A, Varigos G: A pilot study to determine the short-term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel controlled feeding trial. Mol Nutr Food Res 52:718–726, 2008.
6. Smith RN, Braue A, Varigos GA, Mann NJ: The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin, surface triglyceride. J Dermatol Sci 50:41–52, 2008.
7. Smith RN, Mann NJ, Braue A, Makelainen H, Varigos JA: The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol 57:247–256, 2007.
8. Kaymak Y, Adisen E, Ilter N, Bideci A, Gurler D, Celik B: Dietary glycemic index and glucose, insulin-like growth factor-1, insulinlike growth factor binding protein 3, and leptin levels in patients with acne. J Am Acad Dermatol 57:819–823, 2007.
9. Becker SW, Obermeyer ME: “Modern Dermatology and Syphilology,” 2nd ed. Philadelphia: JB Lippincott Co, pp 590–595, 1947.
10. Ormsby OS, Montgomery H: “Diseases of the Skin,” 8th ed. Philadelphia: Lea & Febiger, p 1365, 1954.
11. Sutton RL Jr: “Diseases of the Skin,” 11th ed. St Louis: Mosby Co, pp 683–690, 1956.
12. Tan J, Vasey K, Fung K: Beliefs and perceptions of patients with acne. J Am Acad Dermatol 44:439–445, 2001.
13. Eichenfield LF, Leyden JJ: Acne: current concepts of pathogenesis and approach to rational treatment. Pediatrician 18:218–223, 1991.
14. Thiboutot DM: Acne: an overview of clinical research findings. Dermatol Clin 15:97–109, 1997.
15. Webster GF: Acne vulgaris: state of the science. Arch Dermatol 135:1101–1102, 1999.
16. Green J, Sinclair RD: Perceptions of acne vulgaris in final-year medical student written examination answers. Australas J Dermatol 42:98–101, 2001.
17. Holt SA, Brand Miller JC, Petocz P: An insulin index of foods: the insulin demand generated by 100-kJ portions of common foods. Am J Clin Nutr 66:1264–1276, 1997.
18. Daly ME, Vale C, Walker M, Alberti KG, Mathers JC: Dietary carbohydrates and insulin sensitivity: a review of the evidence and clinical implications. Am J Clin Nutr 66:1072–1085, 1997.
19. Zammit VA, Waterman IJ, Topping D, McKay G: Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr 131:2074–2077, 2001.
20. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB: Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 21:355–359, 1997.
21. Attia N, Tamborlane WV, Heptulla R, Maggs D, Grozman A, Sherwin RS, Caprio S: The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab 83:1467–1471, 1998.
22. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K: Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-1 in insulin-dependent diabetes. J Clin Endocrinol Metab 79:872–878, 1994.
23. Holly JMP: The physiological role of IGFBP-1. Acta Endocrinol 124:55–62, 1991.
24. Ferry RJ, Cerri RW, Cohen P: Insulin-like growth factor binding proteins: new proteins, new functions. Horm Res 51:53–67, 1999.
25. Rudman SM, Philpott MP, Thomas GA, Kealey T: The role of IGF-I in human skin and its appendages: morphogen as well as mitogen? J Invest Dermatol 109:770–777, 1997.
26. Bol KK, Kiguchi K, Gimenez-Conti I, Rupp T, DiGiovanni J: Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Oncogene 14:1725–1734, 1997.
27. Aizawa H, Niimura M: Elevated serum insulin-like growth factor-I (IGF-1) levels in women with postadolescent acne. J Dermatol 22:249–252, 1995.
28. Aizawa H, Niimura M: Mild insulin resistance during oral glucose tolerance test (OGTT) in women with acne. J Dermatol 23:526–529, 1996.
29. Cordain L, Eades M, Eades M: Hyperinsulinemic diseases of civilization: more than just Syndrome X. Comp Biochem Physiol A Mol Integr Physiol 136:95–112, 2003.
30. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P: The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9:361–367, 1995.
31. Edmondson SR, Murashita MM, Russo VC, Wraight CJ, Werther GA: Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGFb1. J Cell Physiol 179:201–207, 1999.
32. Evans TR, Kaye SB: Retinoids: present role and future potential. Br J Cancer 80:1–8, 1999.
33. Yang Q, Mori I, Shan L, Nakamura M, Nakamura Y, Utsunomiya H, Yoshimura G, Suzuma T, Tamaki T, Umemura T, Sakurai T, Kakudo K: Biallelic inactivation of retinoic acid receptor B2 gene by epigenetic change in breast cancer. Am J Pathol 158:299–303, 2001.
34. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, Cohen P: Direct functional interaction between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem 275:33607–33613, 2000.
35. Wendling O, Chambon P, Mark M: Retinoid X receptors are essential for early mouse development and placentogenesis. Proc Natl Acad Sci U S A 96:547–551, 1999.
36. Chiba H, Clifford J, Metzger D, Chambon P: Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells. Mol Cell Biol 17:3013–3020, 1997.
37. Grimberg A, Cohen P: Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 183:1–9, 2000.
38. Thacher SM, Vasudevan J, Chandraratna RA: Therapeutic applications for ligands of retinoid receptors. Curr Pharm Des 6:25–58, 2000.
39. Barbieri RL, Smith S, Ryan KJ: The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril 50:197–212, 1988.
40. Cara JF: Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production. Horm Res 42:49–54, 1994.
41. Bebakar WM, Honour JW, Foster D, Liu YL, Jacobs HS: Regulation of testicular function by insulin and transforming growth factor-beta. Steroids 55:266–270, 1990.
42. De Mellow JS, Handelsman DJ, Baxter RC: Short-term exposure to insulin-like growth factors stimulates testosterone production by testicular interstitial cells. Acta Endocrinol 115:483–489, 1987.
43. Crave JC, Lejeune H, Brebant C, Baret C, Pugeat M: Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastomaderived (Hep G2) cells. J Clin Endocrinol Metab 80:1283–1289, 1995.
44. Singh A, Hamilton-Fairley D, Koistinen R, Seppala M, James VH, Franks S, Reed MJ: Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells. J Endocrinol 124:R1–R3, 1990.
45. Pugeat M, Crave JC, Elmidani M, Nicolas MH, Garoscio-Cholet M, Lejeune H, Dechaud H, Tourniaire J: Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin. J Steroid Biochem Mol Biol 40:841–849, 1991.
46. Vermeulen A, Kaufman JM, Giagulli VA: Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 81:1821–1826, 1996.
47. Pfeilschifter J, Scheidt-Nave C, Leidig-Bruckner G, Woitge HW, Blum WF, Wuster C, Haack D, Ziegler R: Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50-to 80-yearold men and women. J Clin Endocrinol Metab 81:2534–2540, 1996.
48. Erfurth EM, Hagmar LE, Saaf M, Hall K: Serum levels of insulinlike growth factor I and insulin-like growth factor-binding protein 1 correlate with serum free testosterone and sex hormone binding globulin levels in healthy young and middle-aged men. Clin Endocrinol (Oxf) 44:659–664, 1996.
49. Klinger B, Anin S, Silbergeld A, Eshet R, Laron Z: Development of hyperandrogenism during treatment with insulin-like growth hormone factor-I (IGF-I) in female patients with Laron syndrome. Clin Endocrinol (Oxf) 48:81–87, 1998.
50. Thiboutot D, Gilliland K, Light J, Lookingbill D: Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol 135:1041–1045, 1999.
51. Franks S: Polycystic ovary syndrome. N Engl J Med 13:853–861, 2003.
52. Dunaif A, Segal K, Shelley D, Green G, Dorbrjansky A: Profound peripheral insulin resistance, independent of obesity in polycystic ovary syndrome. Diabetes 38:1165–1174, 1989.
53. Bourne S, Jacobs A: Observations on acne, seborrhoea, and obesity. BMJ 1:1268–1270, 1956.
54. Fulton J, Plewig G, Kligman A: Effect of chocolate on acne vulgaris. JAMA 210:2071–2074, 1969.
55. Mackie B, Mackie L: Chocolate and acne. Aust J Dermatol 15:103–109, 1974.
56. Anderson P: Foods as the cause of acne. Am J Fam Pract 3:102–103, 1971.
57. Margin P, Pond D, Smith W, Watson A: A systematic review of the evidence for ‘myths and misconceptions’ in acne management: diet, face-washing and sunlight. Fam Pract 22:62–70, 2005.
58. Chiu A, Chon S, Kimball A: The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress. Arch Dermatol 139:897–900, 2003.
59. Adebamowo C, Spiegelman D, Danby F, Frazier A, Willett W, Holmes M: High school dietary dairy intake and teenage acne. J Am Acad Dermatol 52:207–214, 2005.